Various toxicities: case report

    This is a preview of subscription content, access via your institution.


    1. Casertano S, et al. Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti-rituximab antibodies. European Journal of Neurology 27: 2673-2675, No. 12, Dec 2020. Available from: URL: http://doi.org/10.1111/ene.14498

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Rituximab. Reactions Weekly 1838, 476 (2021). https://doi.org/10.1007/s40278-021-89793-5

    Download citation